Technetium and rhenium (I and V) complexes for radiopharmaceutical applications by Radford, Lauren L., 1987-
Technetium and Rhenium (I and V) Complexes for Radiopharmaceutical Applications 
Lauren Radford 
Drs. Silvia Jurisson and Heather Hennkens, Dissertation Supervisors 
Abstract 
The chelation of technetium and rhenium has been explored to create complexes for 
radiopharmaceutical applications. Two 99mTc (I) radiopharmaceuticals have been created that seek to 
target somatostatin receptors (SSTRs), which are commonly overexpressed on neuroendocrine tumor 
tissues. The complexes use tridentate, bifunctional chelating agents (BFCAs) to chelate the 
99mTc(CO)3+ core while tethering it to an antagonist somatostatin receptor-seeking peptide (sst2-
ANT). 
The histidine-derived tridentate BFCAs used either an [N,S,N] or an [N,S,O] donor system to 
form complexes with 99mTc/Re(CO)3+. The non-radioactive Re complexes were synthesized to verify 
the products made on the radiotracer level as well as determine receptor-binding affinity. Fac-
[Re(CO)3(NSN-sst2-ANT)]+ and fac-[Re(CO)3(NSO-sst2-ANT)] both exhibit low nanomolar 
affinities for somatostatin receptor subtype two (SSTR2), as determined in AR42J cells. The radio-
tracer products fac-[99mTc(CO)3(NSN-sst2-ANT)]+ and fac-[99mTc(CO)3(NSO-sst2-ANT)] both 
exhibited high in vitro stability during challenges in cysteine, histidine, and mouse serum. Mouse 
biodistribution and imaging studies were also performed to determine the pharmacokinetic properties 
of each complex. 
Lastly, complexation of Re and Tc using a tetradentate diphosphinedithiol (DPDT) ligand 
was explored in order to determine whether or not the reducing abilities of the P2S2 donor system 
would aid in the stability of rhenium in the +5 oxidation state. Synthesis of ReO(DPDT) led to the 
formation of a highly stable Re (V) complex, which remained stable in oxidative environments over 
a period of 5 months. Macroscale reactions using the DPDT ligand to synthesize the 99Tc counterpart 
led to the formation of Tc (III) complexes directly from Tc (VII). 
